Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi. - Wikidata - wikimedia - TriplyDB

Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi.

Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi.

http://www.wikidata.org/entity/Q37712861

about

Efficacy of Six-Week Extended-Dose Nevirapine Varies by Infant Birth Weight with Greatest Relative Efficacy in Low Birth Weight Infants.Evidence on the cost-effectiveness of lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV: implications for resource-limited countries in sub-Saharan Africa.Who will be lost? Identifying patients at risk of loss to follow-up in Malawi. The DREAM Program Experience.

P2860

Q36149804-291DD6E4-C54F-4B7C-BA83-2620D0787AFA Q38647745-266DF350-6ED5-4006-8B7E-7B40FE15F0D6 Q38984892-8AA5E55D-4AFC-42ED-9121-E5987E282D69

P2860

Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi.

http://www.wikidata.org/entity/Q37712861

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 December 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Comparative cost-effectiveness ...... transmission of HIV in Malawi.

@en

Comparative cost-effectiveness ...... transmission of HIV in Malawi.

@nl

type

label

Comparative cost-effectiveness ...... transmission of HIV in Malawi.

@en

Comparative cost-effectiveness ...... transmission of HIV in Malawi.

@nl

prefLabel

Comparative cost-effectiveness ...... transmission of HIV in Malawi.

@en

Comparative cost-effectiveness ...... transmission of HIV in Malawi.

@nl

P1433

Q37712861-9032CA5C-83F6-4DD9-A8AC-D759C9C1A992

P1476

Q37712861-01483634-C7C7-4874-931D-E0BD84F2B8B5

P2093

Q37712861-04BCA668-C817-4A08-B4A6-F231744AA3A5

Q37712861-0B4765FB-4F7A-42C7-AF69-E39A2EA813A8

Q37712861-399A2C7C-D141-4D15-9B91-A5A093926E04

Q37712861-CEE1CBBA-EE28-458B-BC0D-D3F8D16267A1

Q37712861-EBD5147C-2DEB-44EC-9EF2-217941B12F52

P2860

Q37712861-08F16E29-C187-474C-8660-9CA24BFE889B

Q37712861-1C862C7B-1490-4C05-B9AF-EA2AB1DD8516

Q37712861-1FA252D6-99B3-4F38-9DDA-4978FC55E330

Q37712861-2899AE9B-F911-499D-9077-5E9E706C6084

Q37712861-2CBFE0D8-FEC9-47E6-8E30-B685492E6B77

Q37712861-33747903-0701-48BA-881A-030E106E9061

Q37712861-37616865-25FE-400F-9623-710CAD5919E1

Q37712861-41873211-28B7-46B6-88AA-0BD5E887C818

Q37712861-4561FC55-B35F-43B6-977F-EA68FDBCB9BA

Q37712861-4C2B0393-B293-45E8-A849-8BDD22100C41

P304

Q37712861-F5536866-9A96-45B0-9BDC-48B57D7E22F8

P31

Q37712861-57DED889-30E8-42AD-AF47-3B835230ED5B

P356

Q37712861-24A848DE-1726-4596-999A-AA3239B07645

P407

Q37712861-0E7DF86F-0CB9-44FE-80F6-DDDE5EDF9356

P433

Q37712861-524880B1-9910-42D9-9CA6-EC6FD860A474

P478

Q37712861-6B3EDE12-6B22-4539-9E0D-D8452CD23164

P50

Q37712861-B6CEBDC1-05E5-45B0-A166-2C9CA14C798D

Q37712861-EC71693C-C6BB-4045-8FD4-0AA8682DA647

P577

Q37712861-2578D285-32CF-46FD-A34B-5EA6991B3454

P698

Q37712861-50E88C57-E3F3-4B87-8049-B370D5C8F254

P921

Q37712861-06FC7C65-F655-40BF-B2B2-FCF5F6D6F2F0

Q37712861-0BE45F16-FD03-42F2-B3AC-A92301D2D12F

Q37712861-B839498A-D704-490C-9CE7-54940790EFFE

P932

Q37712861-03A0AD22-6A4C-49CA-B60C-E209B0AFEF66

P356

QAD.0000000000001009

P1433

P1476

Comparative cost-effectiveness ...... transmission of HIV in Malawi.

@en

P2093

Hannock Tweya

http://www.w3.org/2001/XMLSchema#string

Janne Estill

http://www.w3.org/2001/XMLSchema#string

Lyson Tenthani

http://www.w3.org/2001/XMLSchema#string

Olivia Keiser

http://www.w3.org/2001/XMLSchema#string

Sam Phiri

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of HIV-1 infection with early antiretroviral therapy

Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach

Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis

What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis

Challenges and opportunities for implementing evidence-based antenatal care in Mozambique: a qualitative study

Duration, pattern of breastfeeding and postnatal transmission of HIV: pooled analysis of individual data from West and South African cohorts

Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi

Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study. South African Vitamin A Study Group.

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Antiretroviral regimens in pregnancy and breast-feeding in Botswana.

P304

953-962

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0000000000001009

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Andreas D. Haas

P577

2015-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26691682

http://www.w3.org/2001/XMLSchema#string

P921

HIV transmission

prevention of HIV/AIDS

P932

5359470

http://www.w3.org/2001/XMLSchema#string